VisualSonics Inc. introduced the NeuroPak Deep Brain Imaging System, a novel technology that provides pre-clinical neurology researchers with the capability to image biological and cellular processes in the brains of conscious animals.

It works with the Cellvizio LAB Imaging System, a miniature endoscopic fluorescence microscope, to allow users to repeatedly image a section of a small animal's brain, in real time while the animal is awake and moving freely.

While existing research tools limit access to near-surface imaging on sedated animals, Neuropak Imaging System allows researchers real time access to tissue, deep in the brain of a conscious animal, enabling researchers to determine how the brain reacts to different stimuli in real time.

The NeuroPak System uses a small implant in the skull of the mouse, placed over the area of interest in the brain, which allows repeated, reproducible insertion of the probe for imaging sessions which can be hours in duration. The CerboFlex Probe is a special fiber bundle probe designed to fit the implant that is very flexible and lightweight, thus the mouse is free to move around while the fiber probe is in place. The CellVizio LAB is capable of high resolution, real time imaging of fluorescent tissues, cells and markers at micron levels. Based on a robust, patented confocal technology which employs a high resolution fiber bundle, laser scanning unit and sensitive detector optics, the easy-to-use platform allows real-time imaging of microscopic biology inside a living animal.

"NeuroPak(TM) is the first commercially available means to simultaneously image and correlate cellular events in the intact central nervous system with the behavioral responses of laboratory mice," said David Bates, an Application Scientist at VisualSonics. "This imaging technology will enable groundbreaking research in a myriad of neurological disorders such as Alzheimer's, epilepsy and addiction."

The technique was developed as part of a research collaboration between scientists at Mauna Kea Technologies and the Institut Pasteur in Paris. VisualSonics is the exclusive global distributor for Mauna Kea Technologies pre-clinical imaging technologies, including the Cellvizio LAB In Vivo Fiberoptic Fluorescence Microscope, the NeuroPak Deep Brain Imaging System and the CerboFlex Deep Brain Imaging Probe.

For more information: www.visualsonics.com


Related Content

News | Artificial Intelligence

June 15, 2026 — HOPPR recently announced that HOPPR AI Foundry is now available in AWS Marketplace. The availability ...

Time June 19, 2026
arrow
News | Digital Pathology

June 15, 2026 — Leica Biosystems is expanding the availability of its Aperio GT Elite digital scanner into the EMEA ...

Time June 15, 2026
arrow
News | Radiology Business

June 9, 2026 — Bayer has appointed Dr. Jost Reinhard president of the Radiology business within Bayer’s Pharmaceuticals ...

Time June 12, 2026
arrow
News | Enterprise Imaging

June 9, 2026 — GE HealthCare will showcase its latest enterprise imaging solutions at the Society for Imaging ...

Time June 09, 2026
arrow
News | Innovative Hospitals

May 27, 2026 — Nearly two years after announcing plans for a “real-world” academic-industrial collaboration, GE ...

Time June 03, 2026
arrow
News | Radiology Business

May 22, 2026 — The American College of Radiology (ACR) supports passage of the Medicare Access to Radiology Care Act (S ...

Time May 26, 2026
arrow
News | Radiology Business

May 22, 2026 — U.S. Sens. Boozman, R-AR, and Luján, D-NM, have introduced the Medicare Access to Radiology Care Act ...

Time May 26, 2026
arrow
Feature | Enterprise Imaging | Kyle Hardner

For radiology departments, the imbalance between surging imaging volume and a shortage of trained radiologists is taking ...

Time May 20, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

April 27, 2026 — SimonMed, one of the nation’s largest independent outpatient imaging providers, has announced the ...

Time May 04, 2026
arrow
News | Computed Tomography (CT)

April 23, 2026 — Royal Philips has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...

Time April 30, 2026
arrow
Subscribe Now